Product Information
BANOPHEN 25 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.0534 per EA under NDC 00904723780. Its NADAC has been published 202 times since Nov 23, 2022.
Strength
25 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904723780
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIPHENHYDRAMINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
4/14/2022
Pharmacological Classes
Price Statistics
The NADAC for BANOPHEN 25 MG CAPSULE has been published 202 times since Nov 23, 2022, and over the history we have for it it has risen 57.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0534 per EA |
|---|---|
| All-time high | $0.0640 (Feb 11, 2026) |
| All-time low | $0.0303 (Dec 21, 2022) |
| 52-week high | $0.0640 |
| 52-week low | $0.0528 |
| Median price | $0.0432 |
| Average price | $0.0461 |
| Largest weekly change | +27.5% (Jan 18, 2023) |
| Weeks tracked | 202 |
| Tracking since | Nov 23, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diphenhydramine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BANOPHEN 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BANOPHEN 25 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.0534 per EA (NDC 00904723780), effective Sep 30, 2026.
How has the price of BANOPHEN 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BANOPHEN 25 MG CAPSULE has risen 57.8%. It has been tracked across 202 weekly CMS publications since Nov 23, 2022.
What are the highest and lowest recorded NADAC prices for BANOPHEN 25 MG CAPSULE?
Since Nov 23, 2022, the NADAC for BANOPHEN 25 MG CAPSULE has ranged from a low of $0.0303 (Dec 21, 2022) to a high of $0.0640 (Feb 11, 2026), with a median of $0.0432 per EA.
Are there cheaper alternatives to BANOPHEN 25 MG CAPSULE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DIPHENHYDRAMINE 25 MG CAPSULE, is $0.0415 per EA — about 22% below BANOPHEN 25 MG CAPSULE.
Who manufactures BANOPHEN 25 MG CAPSULE?
BANOPHEN 25 MG CAPSULE (NDC 00904723780) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.